{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:15Z","timestamp":1793209215590,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272994"],"award-info":[{"award-number":["82272994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Program of Shanghai Jiao Tong University","award":["YG2025QNB47"],"award-info":[{"award-number":["YG2025QNB47"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastric cancers are classified into four molecular subtypes according to The Cancer Genome Atlas (TCGA) classification: Epstein-Barr virus-positive (EBV-positive), microsatellite instability-high (MSI-H), chromosomal instability (CIN), and genomically stable (GS). Unlike MSI-H gastric cancer, GS and CIN subtypes exhibit immunologically inert microenvironments and demonstrate minimal response to immune checkpoint blockade (ICB), necessitating novel strategies to overcome immunotherapy resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Through weighted gene co-expression network analysis (WGCNA), we identified the E3 ubiquitin ligase TRIM6 as inversely associated with MSI-H status.\n                      <jats:italic>TRIM6<\/jats:italic>\n                      -knockout murine models and subcutaneous tumors were subjected to flow cytometry, RNA sequencing, immunoblotting, and ubiquitination assays to characterize tumor-infiltrating lymphocytes (TILs), pathway activation, and TRIM6-mediated regulation of the cGAS-STING axis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hypermethylation-mediated\n                      <jats:italic>TRIM6<\/jats:italic>\n                      downregulation distinguished MSI-H from microsatellite stable (MSS) gastric cancers. Clinically,\n                      <jats:italic>TRIM6<\/jats:italic>\n                      expression inversely correlated with cytotoxic T lymphocyte (CTL) infiltration and anti-PD-1\/PD-L1 therapeutic efficacy. Mechanistically, TRIM6 catalyzed K27-linked polyubiquitination of cGAS, triggering its proteasomal degradation and consequent suppression of the cGAS-STING pathway.\n                      <jats:italic>TRIM6<\/jats:italic>\n                      ablation enhanced CD8\n                      <jats:sup>+<\/jats:sup>\n                      T lymphocytes infiltration via cGAS-mediated innate immune response and synergized with anti-PD-L1 therapy in MSS gastric tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results elucidate TRIM6-mediated suppression of antitumor immunity as a novel mechanism underlying ICB resistance in MSS gastric cancer, positioning TRIM6 as both a predictive biomarker and therapeutic target for immunologically cold subtypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03513-5","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T05:13:37Z","timestamp":1755234817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["TRIM6 ablation reverses ICB resistance in MSS gastric cancer by unleashing cGAS-STING-dependent antitumor immunity"],"prefix":"10.1186","volume":"44","author":[{"given":"Yinan","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quansheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"3513_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","DOI":"10.3322\/caac.21654"},{"issue":"7517","key":"3513_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"5","key":"3513_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449\u201356.","journal-title":"Nat Med"},{"issue":"3","key":"3513_CR4","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3513_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","volume":"7","author":"J Chao","year":"2021","unstructured":"Chao J, Fuchs CS, Shitara K, Tabernero J, Muro K, Van Cutsem E, et al. Assessment of pembrolizumab therapy for the treatment of microsatellite Instability-High gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials. JAMA Oncol. 2021;7(6):895\u2013902.","journal-title":"JAMA Oncol"},{"issue":"3","key":"3513_CR6","doi-asserted-by":"publisher","first-page":"e004080","DOI":"10.1136\/jitc-2021-004080","volume":"10","author":"Y Bai","year":"2022","unstructured":"Bai Y, Xie T, Wang Z, Tong S, Zhao X, Zhao F, et al. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer. J Immunother Cancer. 2022;10(3):e004080.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"3513_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 Inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449\u201358.","journal-title":"Nat Med"},{"issue":"5","key":"3513_CR8","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1002\/mco2.343","volume":"4","author":"LJ Wang","year":"2023","unstructured":"Wang LJ, Geng H, Liu YJ, Liu L, Chen YH, Wu FC, et al. Hot and cold tumors: immunological features and the therapeutic strategies. Medcomm. 2023;4(5):e343.","journal-title":"Medcomm"},{"issue":"5","key":"3513_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10120-023-01405-1","volume":"26","author":"C Huang","year":"2023","unstructured":"Huang C, Chen B, Wang X, Xu J, Sun L, Wang D, et al. Gastric cancer mesenchymal stem cells via the CXCR2\/HK2\/PD-L1 pathway mediate immunosuppression. Gastric Cancer. 2023;26(5):691\u2013707.","journal-title":"Gastric Cancer"},{"issue":"11","key":"3513_CR10","doi-asserted-by":"publisher","first-page":"e007669","DOI":"10.1136\/jitc-2023-007669","volume":"11","author":"K Lv","year":"2023","unstructured":"Lv K, Sun M, Fang H, Wang J, Lin C, Liu H, et al. Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. J Immunother Cancer. 2023;11(11):e007669.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"3513_CR11","doi-asserted-by":"publisher","first-page":"e1578","DOI":"10.1002\/ctm2.1578","volume":"14","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yu K, Zhang Z, Gu Y, Gu Y, Li W, et al. Blockade of V-domain Immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer. Clin Transl Med. 2024;14(2):e1578.","journal-title":"Clin Transl Med"},{"issue":"3","key":"3513_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","volume":"74","author":"Y Li","year":"2025","unstructured":"Li Y, Zheng Y, Huang J, Nie RC, Wu QN, Zuo Z, et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint Blockade in gastric cancer peritoneal metastases. Gut. 2025;74(3):350\u201363.","journal-title":"Gut"},{"issue":"7734","key":"3513_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","volume":"564","author":"XB Meng","year":"2018","unstructured":"Meng XB, Liu XW, Guo XD, Jiang ST, Chen TT, Hu ZQ, et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 2018;564(7734):130\u20135.","journal-title":"Nature"},{"issue":"7686","key":"3513_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature25015","volume":"553","author":"JF Zhang","year":"2018","unstructured":"Zhang JF, Bu X, Wang HZ, Zhu YS, Geng Y, Nihira NT, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via Cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553(7686):91\u20135.","journal-title":"Nature"},{"issue":"12","key":"3513_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41423-023-01093-y","volume":"20","author":"JZ Yu","year":"2023","unstructured":"Yu JZ, Cui JK, Zhang X, Xu H, Chen Z, Li Y, et al. The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8 T-cell immunity. Cell Mol Immunol. 2023;20(12):1445\u201356.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3513_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler M, Schonig K, Eckert H, Eschstruth A, Mianne J, Renaud JB, et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17(1):148.","journal-title":"Genome Biol"},{"issue":"5","key":"3513_CR17","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.18632\/oncotarget.13918","volume":"8","author":"EA Kautto","year":"2017","unstructured":"Kautto EA, Bonneville R, Miya J, Yu LB, Krook MA, Reeser JW, et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget. 2017;8(5):7452\u201363.","journal-title":"Oncotarget"},{"key":"3513_CR18","doi-asserted-by":"crossref","unstructured":"Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ et al. Landscape of microsatellite instability across 39 cancer types. Jco Precis Oncol. 2017;2017:PO.17.00073.","DOI":"10.1200\/PO.17.00073"},{"issue":"5","key":"3513_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao JJ, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"43","key":"3513_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. P Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"P Natl Acad Sci USA"},{"issue":"9","key":"3513_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-021-00732-8","volume":"23","author":"G Zhu","year":"2021","unstructured":"Zhu G, Herlyn M, Yang X. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. Nat Cell Biol. 2021;23(9):978\u201391.","journal-title":"Nat Cell Biol"},{"issue":"W1","key":"3513_CR22","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"3513_CR23","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"BB Ru","year":"2019","unstructured":"Ru BB, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"issue":"10","key":"3513_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"3513_CR25","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1038\/s41467-022-34403-5","volume":"13","author":"Z Tang","year":"2022","unstructured":"Tang Z, Wang Y, Liu D, Wang X, Xu C, Yu Y, et al. The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction. Nat Commun. 2022;13(1):6807.","journal-title":"Nat Commun"},{"issue":"4","key":"3513_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell. 2017;171(4):934\u201349.","journal-title":"Cell"},{"key":"3513_CR27","doi-asserted-by":"crossref","unstructured":"Chen TT, Chen X, Zhang SS, Zhu JW, Tang BX, Wang AK, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinf. 2021;19(4):578\u201383.","DOI":"10.1016\/j.gpb.2021.08.001"},{"issue":"D1","key":"3513_CR28","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"YB Xue","year":"2022","unstructured":"Xue YB, Bao YM, Zhang Z, Zhao WM, Xiao JF, He SM, et al. Database resources of the National genomics data center, China National center for bioinformation in 2022. Nucleic Acids Res. 2022;50(D1):D27\u201338.","journal-title":"Nucleic Acids Res"},{"key":"3513_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"3513_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"3513_CR31","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18(11):1427\u201331.","journal-title":"Bioinformatics"},{"issue":"17","key":"3513_CR32","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","volume":"25","author":"SA Weiss","year":"2019","unstructured":"Weiss SA, Wolchok JD, Sznol M. Immunotherapy of melanoma: facts and hopes. Clin Cancer Res. 2019;25(17):5191\u2013201.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3513_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13619-025-00232-2","volume":"14","author":"WS Liu","year":"2025","unstructured":"Liu WS, Li LM, Guo LL, Li HJ, Tang ZQ, Wang XF, et al. Dasatinib demonstrates efficacy in organoid derived paclitaxel-resistant deficient mouse gastric adenocarcinoma with peritoneal metastasis. Cell Regen. 2025;14(1):16.","journal-title":"Cell Regen"},{"issue":"4","key":"3513_CR34","first-page":"261","volume":"9","author":"SS Qian","year":"1987","unstructured":"Qian SS, Gao J, Wang JX, Liu Y, Dong HY. [Establishment of a mouse forestomach carcinoma cell line (MFC) with spontaneous hematogenous metastasis and preliminary study of its biological characteristics]. Zhonghua Zhong Liu Za Zhi. 1987;9(4):261\u20134.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"9","key":"3513_CR35","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","volume":"11","author":"M Kwon","year":"2021","unstructured":"Kwon M, An M, Klempner SJ, Lee H, Kim KM, Sa JK, et al. Determinants of response and intrinsic resistance to PD-1 Blockade in microsatellite Instability-High gastric cancer. Cancer Discov. 2021;11(9):2168\u201385.","journal-title":"Cancer Discov"},{"issue":"7","key":"3513_CR36","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1097\/JS9.0000000000001931","volume":"110","author":"P Yu","year":"2024","unstructured":"Yu P, Ding G, Huang X. Genomic and immune microenvironment features influencing chemoimmunotherapy response in gastric cancer with peritoneal metastasis: a retrospective cohort study (110, Pg 3504, 2024). Int J Surg. 2024;110(7):4532\u20134.","journal-title":"Int J Surg"},{"issue":"1","key":"3513_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-021-02120-4","volume":"40","author":"C Li","year":"2021","unstructured":"Li C, Shen Q, Zhang P, Wang T, Liu W, Li R, et al. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS\/STING signaling in gastric cancer cells. J Exp Clin Cancer Res. 2021;40(1):315.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"3513_CR38","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) T cells. Cell. 2024;187(9):2288\u2013304. e27.","journal-title":"Cell"},{"issue":"1","key":"3513_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/BST20160325","volume":"45","author":"D Esposito","year":"2017","unstructured":"Esposito D, Koliopoulos MG, Rittinger K. Structural determinants of TRIM protein function. Biochem Soc Trans. 2017;45(1):183\u201391.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"3513_CR40","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/labinvest.3700117","volume":"84","author":"Y Yao","year":"2004","unstructured":"Yao Y, Tao H, Kim JJ, Burkhead B, Carloni E, Gasbarrini A, et al. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines. Lab Invest. 2004;84(7):915\u201322.","journal-title":"Lab Invest"},{"issue":"5","key":"3513_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0092-8674(00)00077-5","volume":"102","author":"CA Joazeiro","year":"2000","unstructured":"Joazeiro CA, Weissman AM. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 2000;102(5):549\u201352.","journal-title":"Cell"},{"issue":"9","key":"3513_CR42","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","volume":"20","author":"A Reymond","year":"2001","unstructured":"Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20(9):2140\u201351.","journal-title":"EMBO J"},{"issue":"5","key":"3513_CR43","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.celrep.2013.05.008","volume":"3","author":"PJ Kranzusch","year":"2013","unstructured":"Kranzusch PJ, Lee AS, Berger JM, Doudna JA. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 2013;3(5):1362\u20138.","journal-title":"Cell Rep"},{"issue":"6","key":"3513_CR44","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.immuni.2014.04.018","volume":"40","author":"R Rajsbaum","year":"2014","unstructured":"Rajsbaum R, Versteeg GA, Schmid S, Maestre AM, Belicha-Villanueva A, Martinez-Romero C, et al. Unanchored K48-linked Polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKepsilon kinase-mediated antiviral response. Immunity. 2014;40(6):880\u201395.","journal-title":"Immunity"},{"issue":"11","key":"3513_CR45","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1136\/gutjnl-2015-310928corr1","volume":"66","author":"S Sundaresan","year":"2017","unstructured":"Sundaresan S, Kang AJ, Hayes MM. Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids. Gut. 2017;66(11):2012.","journal-title":"Gut"},{"issue":"2","key":"3513_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s43018-023-00686-w","volume":"5","author":"J Leibold","year":"2024","unstructured":"Leibold J, Tsanov KM, Amor C, Ho YJ, Sanchez-Rivera FJ, Feucht J, et al. Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease. Nat Cancer. 2024;5(2):315\u201329.","journal-title":"Nat Cancer"},{"issue":"6349","key":"3513_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 Blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science"},{"issue":"12","key":"3513_CR48","doi-asserted-by":"publisher","first-page":"e15661","DOI":"10.1371\/journal.pone.0015661","volume":"5","author":"B Timmermann","year":"2010","unstructured":"Timmermann B, Kerick M, Roehr C, Fischer A, Isau M, Boerno ST, et al. Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS ONE. 2010;5(12):e15661.","journal-title":"PLoS ONE"},{"issue":"1","key":"3513_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ccell.2020.11.006","volume":"39","author":"C Lu","year":"2021","unstructured":"Lu C, Guan J, Lu S, Jin Q, Rousseau B, Lu T, et al. DNA sensing in mismatch Repair-Deficient tumor cells is essential for Anti-tumor immunity. Cancer Cell. 2021;39(1):96\u2013108. e6.","journal-title":"Cancer Cell"},{"issue":"6121","key":"3513_CR50","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786\u201391.","journal-title":"Science"},{"issue":"6148","key":"3513_CR51","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","volume":"341","author":"D Gao","year":"2013","unstructured":"Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science. 2013;341(6148):903\u20136.","journal-title":"Science"},{"issue":"7485","key":"3513_CR52","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nature12862","volume":"505","author":"JW Schoggins","year":"2014","unstructured":"Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. 2014;505(7485):691\u20135.","journal-title":"Nature"},{"issue":"1","key":"3513_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-023-43743-9","volume":"15","author":"H Lv","year":"2024","unstructured":"Lv H, Zong Q, Chen C, Lv G, Xiang W, Xing F, et al. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer. Nat Commun. 2024;15(1):6.","journal-title":"Nat Commun"},{"issue":"5","key":"3513_CR54","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","volume":"29","author":"L Schadt","year":"2019","unstructured":"Schadt L, Sparano C, Schweiger NA, Silina K, Cecconi V, Lucchiari G, et al. Cancer-Cell-Intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 2019;29(5):1236\u2013e487.","journal-title":"Cell Rep"},{"issue":"4","key":"3513_CR55","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","volume":"49","author":"A Marcus","year":"2018","unstructured":"Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-Derived cGAMP triggers a STING-Mediated interferon response in Non-tumor cells to activate the NK cell response. Immunity. 2018;49(4):754\u201363. e4.","journal-title":"Immunity"},{"issue":"7","key":"3513_CR56","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1073\/pnas.1621363114","volume":"114","author":"H Wang","year":"2017","unstructured":"Wang H, Hu S, Chen X, Shi H, Chen C, Sun L, et al. cGAS is essential for the antitumor effect of immune checkpoint Blockade. Proc Natl Acad Sci U S A. 2017;114(7):1637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3513_CR57","doi-asserted-by":"publisher","first-page":"20859","DOI":"10.1038\/s41598-024-71974-3","volume":"14","author":"R Kanoda","year":"2024","unstructured":"Kanoda R, Nakajima S, Fukai S, Saito M, Saito K, Suzuki H, et al. High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8(+) T cells in dMMR\/MSI-H gastric cancer. Sci Rep. 2024;14(1):20859.","journal-title":"Sci Rep"},{"issue":"1","key":"3513_CR58","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1038\/s41467-024-54850-6","volume":"15","author":"F Wen","year":"2024","unstructured":"Wen F, Han Y, Zhang H, Zhao Z, Wang W, Chen F, et al. Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression. Nat Commun. 2024;15(1):10543.","journal-title":"Nat Commun"},{"issue":"1","key":"3513_CR59","doi-asserted-by":"publisher","first-page":"e010460","DOI":"10.1136\/jitc-2024-010460","volume":"13","author":"Z Sun","year":"2025","unstructured":"Sun Z, Shi M, Xia J, Li X, Chen N, Wang H, et al. HDAC and MEK Inhibition synergistically suppresses HOXC6 and enhances PD-1 Blockade efficacy in BRAF(V600E)-mutant microsatellite stable colorectal cancer. J Immunother Cancer. 2025;13(1):e010460.","journal-title":"J Immunother Cancer"},{"issue":"10","key":"3513_CR60","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, Fang Y, Liang W, Wong CC, Qin H, Gao Y, et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42(10):1729\u2013e17468.","journal-title":"Cancer Cell"},{"key":"3513_CR61","doi-asserted-by":"publisher","first-page":"116958","DOI":"10.1016\/j.biopha.2024.116958","volume":"177","author":"KC Huang","year":"2024","unstructured":"Huang KC, Ke TW, Lai CY, Hong WZ, Chang HY, Lee CY, et al. Inhibition of DNMTs increases neoantigen-reactive T-cell toxicity against microsatellite-stable colorectal cancer in combination with radiotherapy. Biomed Pharmacother. 2024;177:116958.","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03513-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:38:24Z","timestamp":1757392704000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03513-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03513-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University (Approval Number: A2024358). Human gastric cancer specimens were collected after obtaining written informed consent from patients, and the study protocol was approved by the Ethics Committee of Fudan University (Approval Number: B2021-449R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}